LBA39IMmotion150: Novel radiological endpoints and updated...

LBA39IMmotion150: Novel radiological endpoints and updated data from a randomized phase II trial investigating atezolizumab (atezo) with or without bevacizumab (bev) vs sunitinib (sun) in untreated metastatic renal cell carcinoma (mRCC)

Powles, T., McDermott, D.F., Rini, B., Motzer, R.J., Atkins, M.B., Fong, L., Joseph, R.W., Pal, S.K., Ravaud, A., Bracarda, S., Rodriguez, C. Suarez, Maio, M., Gore, M., Grünwald, V., Staehler, M., Qi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx440.033
Date:
September, 2017
File:
PDF, 67 KB
english, 2017
Conversion to is in progress
Conversion to is failed